Previous 10 | Next 10 |
2023-04-18 09:09:31 ET The U.S. Food and Drug Administration (FDA) granted 510(k) clearance to Masimo' ( NASDAQ: MASI ) Rad-G with Temperature. Rad-G with Temperature is a handheld monitor which provides SET pulse oximetry, respiration rate from the pleth (RRp),...
Masimo (NASDAQ: MASI) today announced that the Rad-G ® with Temperature has received FDA 510(k) clearance. Rad-G with Temperature is a rugged, versatile, handheld monitor that provides clinically proven SET ® pulse oximetry, respiration rate from the pleth (RRp ® ), a...
Shares of Masimo Corporation (NASDAQ: MASI) traded at a new 52-week high today and are currently trading at $194.39. So far today, approximately 158.72k shares have been exchanged, as compared to an average 30-day volume of 264.11k shares. Masimo Corporation develops, manufactures, and market...
2023-04-03 12:02:17 ET Masimo ( NASDAQ: MASI ) said the U.S. FDA granted De Novo to Masimo Opioid Halo, an opioid overdose prevention and alert system. The status makes the system the first and only FDA-cleared monitoring solution for detecting opioid-induced respir...
Opioid Halo Is Indicated for the Detection of Opioid-Induced Respiratory Depression, with Escalating Alarms to Alert Loved Ones That Help Is Needed De Novo Authorizes Both Over-the-Counter (OTC) Use, on Adults and Children Age 15 and Up, and Prescription Use Masimo (NASDAQ: ...
First of Its Kind Smartwatch Combines Masimo’s Accurate, Continuous Health Tracking Technology and Breakthrough Features in a Premium, Elegant Watch Masimo (NASDAQ: MASI), a global leader in pulse oximetry and innovative noninvasive monitoring technologies, unveiled the newes...
2023-03-23 10:28:56 ET Pulse oximetry company Masimo Corporation ( NASDAQ: MASI ) announced several changes to its board of directors on Thursday, including a lead independent director amid a proxy battle with activist investor Politan Capital Management. Masimo ( MASI )...
H Michael Cohen Selec ted as Lead Independent Director Two Additional New Directors to Be Named to Board Following Consultation with Stockholders Significant Governance Changes Announced, Including Termination of Rights Agreement and Plan to Declassify Board Masi...
2023-03-23 05:08:53 ET Summary Masimo Corporation is a healthcare business that intends to improve the quality of life of its customers. I assumed that management will try to expand through new product categories, and will successfully maintain its leading position in technologica...
2023-03-17 18:41:09 ET Summary Masimo Corporation shares fell off a cliff early in 2022 amidst the pullback in momentum names and a poorly received deal for Sound. I like the long-term trajectory of the business and gave management the benefit of the doubt, believing it was an ove...
News, Short Squeeze, Breakout and More Instantly...
Conference call and webcast to begin at 1:30 p.m. PT (4:30 p.m. ET) Masimo (NASDAQ: MASI) will release second quarter 2024 financial results for the period ended March 30, 2024, after the market closes on Tuesday, August 6, 2024. The conference call to review the results will begin at 1...
Politan Will Take All Necessary Action to Ensure That the Annual Meeting Is Not Delayed Any Further Beyond September 19 and Hopefully Is Held Sooner Politan Capital Management (together with its affiliates, “Politan”), an 8.9% shareholder of Masimo Corporation (“Mas...
Masimo Corporation (“Masimo” or the “Company”) (Nasdaq: MASI), a global leader in noninvasive monitoring technologies and audio products, today announced that it has commenced litigation against Politan Capital Management LP (“Politan”) in federal court i...